FATE
Fate Therapeutics Inc
Price:
1.16
USD
Volume:
788,578
United States | Biotechnology
FATE Gross Margin
As of 2025-05-24, the Gross Margin of Fate Therapeutics Inc (FATE) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
FATE Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 7775.2% |
| 2023-12-31 | - |
| 2022-12-31 | - |
| 2021-12-31 | - |
| 2020-12-31 | - |
| 2019-12-31 | - |
| 2018-12-31 | - |
| 2017-12-31 | - |
| 2016-12-31 | - |
| 2015-12-31 | - |
FATE Gross Margin - Peers Comparison